- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on BRCA1-associate Malignancies
Total 3505 results
-
PfizerMedivation, Inc.; Myriad Genetic Laboratories, Inc.TerminatedBreast Neoplasms | BRCA 1 Gene Mutation | BRCA 2 Gene MutationUnited States, Spain, United Kingdom, Germany, France
-
University of UtahTerminatedHigh Risk Hematologic MalignanciesUnited States
-
King Faisal Specialist Hospital & Research CenterCompletedTransplantation for Hematologic MalignanciesSaudi Arabia
-
German Cancer Research CenterRecruiting
-
Regeneron PharmaceuticalsTerminatedAdvanced PD-L1 Positive MalignanciesUnited States
-
OncoMed Pharmaceuticals, Inc.CompletedRelapsed or Refractory Lymphoid MalignanciesUnited States
-
Washington University School of MedicineCompletedSolid Tumors | Advanced Gastrointestinal MalignanciesUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruitingAdvanced Solid Tumors and Hematological Malignancies
-
iOMEDICO AGBristol-Myers Squibb; Roche Pharma AGCompletedAdvanced Solid Tumors or Hematologic MalignanciesGermany
-
Xiaoxiang ChenUnknownNeoplasms | Neoplasms by Histologic Type | Urogenital Neoplasms | Neoplasms by Site | Carcinoma | Neoplasms, Glandular and Epithelial | Genital Neoplasms, Female | Endocrine System Diseases | Ovarian Diseases | Adnexal Diseases | Gonadal Disorders | Endocrine Gland Neoplasms | Ovarian Neoplasms | Fallopian Tube Neoplasms and other conditionsChina
-
Institute of Hematology & Blood Diseases HospitalJuventas Cell Therapy Ltd.AvailableRelapsed and Refractory Hematological MalignanciesChina
-
Shandong UniversityJuventas Cell Therapy Ltd.UnknownRelapsed or Refractory Hematological MalignanciesChina
-
Shanghai Hengrui Pharmaceutical Co., Ltd.RecruitingAdvanced Or Metastatic Solid Tumor MalignanciesChina
-
Astellas Pharma Global Development, Inc.TerminatedNon-hematologic Malignancies | Pharmacokinetics of ASP9853United States
-
AstraZenecaCompletedCancer | Solid Tumors | Advanced Solid MalignanciesJapan
-
AstraZenecaTerminatedCancer | Solid Tumors | Advanced Solid MalignanciesJapan
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Peking University People's Hospital; The First Affiliated Hospital of Zhengzhou... and other collaboratorsRecruitingCD7-positive Relapsed/Refractory Lymphoid Hematologic MalignanciesChina
-
Haisco Pharmaceutical Group Co., Ltd.RecruitingRelapsed/Refractory B-Cell MalignanciesChina, Australia
-
Minghui Pharmaceutical (Shanghai) LTDRecruitingRelapsed/Refractory B-cell MalignanciesChina
-
Mirati Therapeutics Inc.Active, not recruitingAdvanced or Metastatic Solid MalignanciesUnited States
-
Gilead SciencesCompletedRelapsed/Refractory B-cell MalignanciesFrance, United Kingdom
-
858 Therapeutics, Inc.RecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Prostate Cancer | Endometrial Cancer | Epithelial Ovarian Cancer | BRCA1 Mutation | BRCA2 Mutation | Advanced or Metastatic Solid Tumors | ER+ Breast Cancer | Castrate Resistant Prostate Cancer | BRCA MutationUnited States
-
Pomeranian Medical University SzczecinMaria Sklodowska-Curie National Research Institute of Oncology; Regional Oncology...UnknownBRCA1 Mutation | Breast Cancer Invasive NosPoland
-
Zhuhai Yufan Biotechnologies Co., LtdRecruitingAdvanced Solid Tumor | Advanced Solid MalignanciesChina
-
Zhuhai Yufan Biotechnologies Co., LtdRecruitingAdvanced Solid Tumor | Advanced Solid MalignanciesUnited States
-
Novita Pharmaceuticals, Inc.RecruitingAdvanced or Metastatic Solid Tumor MalignanciesUnited States
-
Mentrik Biotech, LLCUnknownPreviously Treated CD20+ B-cell MalignanciesUnited States
-
Xiaoxiang ChenRecruitingNeoplasms | Neoplasms by Histologic Type | Urogenital Neoplasms | Neoplasms by Site | Carcinoma | Neoplasms, Glandular and Epithelial | Genital Neoplasms, Female | Ovarian Diseases | Adnexal Diseases | Carcinoma, Ovarian Epithelial | Ovarian Cancer | Angiogenesis | Genital Diseases, Female | Antineoplastic Agents | BRCA1... and other conditionsChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnPancreatic Ductal Adenocarcinoma | Stage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Homologous Recombination Deficiency | Stage IIA Pancreatic Cancer AJCC v8 | Stage IIB Pancreatic Cancer AJCC v8 | ATM Gene Mutation | Deleterious BRCA1 Gene... and other conditions
-
National Cancer Institute (NCI)CompletedBRCA1 Gene Mutation | BRCA2 Gene Mutation | Recurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Negative | Progesterone Receptor Positive | Triple-Negative Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast... and other conditionsUnited States
-
Affiliated Hospital to Academy of Military Medical...Beijing JD Biotech Co. LTD.RecruitingAdult Relapsed/Refractory B-cell Hematologic MalignanciesChina
-
University of Illinois at ChicagoRecruitingRelapsed or Refractory Hematologic MalignanciesUnited States
-
Sunshine Lake Pharma Co., Ltd.Active, not recruitingRelapsed or Refractory B-cell Hematologic MalignanciesChina
-
Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of MedicineWithdrawnLymphoid Hematological Malignancies | Umbilical Cord Blood Transplant
-
AmgenTerminatedAdvanced Non-Central Nervous System (CNS) MalignanciesUnited States
-
Hospital Alemão Oswaldo CruzMinistry of Health, BrazilRecruitingHealthcare-Associated Pneumonia | Ventilator-Associated Pneumonia | Healthcare Associated InfectionBrazil
-
PfizerTerminatedLocally Advanced or Metastatic Solid Tumors | Genes, BRCA 1United States, Belgium, Spain, Denmark, Japan, France, Italy, Netherlands, United Kingdom
-
Mundipharma K.K.CompletedRecurrent or Refractory T/NK-cell MalignanciesJapan
-
GigaGen, Inc.National Cancer Institute (NCI)RecruitingAdvanced or Metastatic Solid Tumor MalignanciesUnited States
-
AstraZenecaTerminatedCancer | Advanced Solid MalignanciesUnited States, Italy, United Kingdom, France, Germany, Spain, Netherlands
-
AstraZenecaTerminatedSolid Tumors | Advanced Solid Malignancies | Cancer,United States
-
National Cancer Institute (NCI)RecruitingMesothelioma | Familial Cancer | BRCA1-Associated Protein-1 (BAP1) Mutations | Tumor Predisposition Syndrome (TPDS)United States
-
Pomeranian Medical University SzczecinMaria Sklodowska-Curie National Research Institute of OncologyCompletedMetastatic Breast Cancer | BRCA1 MutationPoland
-
PfizerMedivation, Inc.CompletedBreast Neoplasms | BRCA 1 Gene Mutation | BRCA 2 Gene MutationKorea, Republic of, United States, Australia, Spain, Belgium, France, Ireland, Taiwan, Poland, Germany, Israel, Brazil, United Kingdom, Italy, Russian Federation, Ukraine
-
ExCellThera inc.Memorial Sloan Kettering Cancer CenterRecruitingCord Blood Transplant | High Risk Myeloid MalignanciesUnited States
-
Bristol-Myers SquibbCompletedHER2 or EGFR Expressing Advanced Solid MalignanciesSpain, France
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetic Laboratories, Inc.Active, not recruitingBreast Cancer Metastatic | BRCA 1 Gene Mutation | BRCA 2 Gene MutationItaly, Spain, United States, Czechia, Romania, France, Korea, Republic of, United Kingdom, Hungary, Japan, Peru, Poland, Russian Federation, Turkey, China, Taiwan, Bulgaria, Switzerland, Mexico
-
University of ChicagoCompletedLeukemia | Preleukemia | Advanced Hematologic MalignanciesUnited States
-
AstraZenecaTerminatedSolid MalignanciesUnited States
-
German Cancer Research CenterGerman Consortium for Translational Cancer ResearchCompletedMetastatic and Locally Advanced NRG1-rearranged MalignanciesGermany